← Search & browse all drugs
ANTIINFECTIVES FOR SYSTEMIC USE › ANTIBACTERIALS FOR SYSTEMIC USE › OTHER BETA-LACTAM ANTIBACTERIALS › Third-generation cephalosporins
cefpodoxime and beta-lactamase inhibitor
J01DD64
Forms & Strengths
- Oral suspension: cefpodoxime proxetil equivalent to 100 mg cefpodoxime per 5 mL when reconstituted (often formulated with clavulanate potassium or similar beta-lactamase inhibitor where commercially available)
- Tablet: cefpodoxime 100 mg / beta-lactamase inhibitor
- Tablet: cefpodoxime 200 mg / beta-lactamase inhibitor
Adult Dosing
- Acute bacterial exacerbation of chronic bronchitis: 200 mg orally every 12 hours for 10 days
- Community-acquired pneumonia: 200 mg orally every 12 hours for 14 days
- Uncomplicated urinary tract infections: 100 mg orally every 12 hours for 7 days
- Skin and skin structure infections: 400 mg orally every 12 hours for 7 to 14 days
Pediatric Dosing
- Children 2 months to 12 years: Acute otitis media: 5 mg/kg body weight (up to 200 mg) orally every 12 hours for 10 days
- Pharyngitis / Tonsillitis: 5 mg/kg body weight (up to 100 mg) orally every 12 hours for 5 to 10 days
- Acute sinusitis: 5 mg/kg body weight (up to 200 mg) orally every 12 hours for 10 days
Indications
- Acute otitis media caused by susceptible isolates of Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis
- Pharyngitis and tonsillitis caused by Streptococcus pyogenes
- Community-acquired pneumonia and acute bacterial exacerbations of chronic bronchitis
- Uncomplicated skin and skin structure infections
- Uncomplicated urinary tract infections (cystitis)
Mechanism of Action
- Cefpodoxime is a third-generation cephalosporin bactericidal agent that inhibits bacterial cell wall synthesis by binding to essential penicillin-binding proteins (PBPs)
- The beta-lactamase inhibitor component inactivates specific plasmid- and chromosomally-mediated beta-lactamases, protecting cefpodoxime from enzymatic degradation by resistant bacterial strains
Contraindications
- Known hypersensitivity to cefpodoxime, other cephalosporins, or any component of the formulation
- History of immediate hypersensitivity reaction (e.g., anaphylaxis) to penicillin or other beta-lactam antibacterial agents
Adverse Reactions
- Diarrhea / loose stools
- Nausea and vomiting
- Abdominal pain
- Headache
- Vaginal fungal infections (candidiasis)
- Hypersensitivity reactions including rash, urticaria, and pruritus
Drug Interactions
- Antacids and H2-receptor antagonists: Decrease the absorption and peak plasma concentration of cefpodoxime
- Probenecid: Inhibits the renal excretion of cephalosporins, leading to increased and prolonged plasma levels
- Nephrotoxic drugs (e.g., aminoglycosides, potent diuretics): May increase the risk of nephrotoxicity
- Oral anticoagulants: May enhance the anticoagulant effect of coumarin derivatives by altering vitamin K gut flora synthesis
Curated Content: Needs Vetting Before Put to Clinical Use